Bacteria-induced intracellular signalling in platelets

References

• Wei AH, Schoenwaelder SM, Andrews RK, Jackson SP. New insights into the haemostatic function of platelets. Br J Haematol 2009;147(4):415–430
   PubMedGoogle Scholar
• Michelson AD. Antiplatelet therapies for the treatment of cardiovascular disease. Nat Rev Drug Discov 2010;9(2):154–169
   PubMed Web of Science ®Google Scholar
• Jennings LK. Role of platelets in atherothrombosis. Am J Cardiol 2009;103(3 Suppl):4A–10A
   PubMedGoogle Scholar
• McNicol A, Israels SJ. Beyond hemostasis: The role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets 2008;8(2):99–117
   PubMedGoogle Scholar
• Seizer P, Gawaz M, May AE. Platelet-monocyte interactions - A dangerous liaison linking thrombosis, inflammation and atherosclerosis. Curr Med Chem 2008;15(20):1976–1980
   PubMed Web of Science ®Google Scholar
• Gleissner CA, von Hundelshausen P, Ley K. Platelet chemokines in vascular disease. Arterioscler Thromb Vasc Biol 2008;28(11):1920–1927
   PubMed Web of Science ®Google Scholar
• Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. Platelet functions beyond hemostasis. J Thromb Haemost 2009;7(11):1759–1766
   PubMed Web of Science ®Google Scholar
• Semple JW, Freedman J. Platelets and innate immunity. Cell Mol Life Sci 2010;67(4):499–511
   PubMed Web of Science ®Google Scholar
• Erpenbeck L, Schon MP. Deadly allies: The fatal interplay between platelets and metastasizing cancer cells. Blood 2010;115(17):3427–3436
   PubMed Web of Science ®Google Scholar
• Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(Suppl 1):S13–S33
   PubMed Web of Science ®Google Scholar
• Semple JW, Italiano Jr JE, Freedman J. Platelets and the immune continuum. Nat Rev Immunol 2011;11(4):264–274
   PubMed Web of Science ®Google Scholar
• Corrales-Medina VF, Madjid M, Musher DM. Role of acute infection in triggering acute coronary syndromes. Lancet Infect Dis 2010;10(2):83–92
   PubMed Web of Science ®Google Scholar
• Ott SJ, El Mokhtari NE, Musfeldt M, Hellmig S, Freitag S, Rehman A, Kühbacher T, Nikolaus S, Namsolleck P, Blaut M, et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 2006;113(7):929–937
   PubMed Web of Science ®Google Scholar
• Nakano K, Nemoto H, Nomura R, Inaba H, Yoshioka H, Taniguchi K, Amano A, Ooshima T. Detection of oral bacteria in cardiovascular specimens. Oral Microbiol Immunol 2009;24(1):64–68
   PubMedGoogle Scholar
• Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol 2006;4(6):445–457
   PubMed Web of Science ®Google Scholar
• Siauw C, Kobsar A, Dornieden C, Beyrich C, Schinke B, Schubert-Unkmeir A, Abele-Horn M, Speer CP, Eigenthaler M. Group B streptococcus isolates from septic patients and healthy carriers differentially activate platelet signaling cascades. Thromb Haemost 2006;95(5):836–849
   PubMedGoogle Scholar
• Arman M, Krauel K, Tilley DO, Weber C, Cox D, Greinacher A, Kerrigan SW, Watson SP. Amplification of bacteria-induced platelet activation is triggered by FcgammaRIIA, integrin alphaIIbbeta3, and platelet factor 4. Blood 2014;123(20):3166–3174
   PubMed Web of Science ®Google Scholar
• Ford I, Ford I, Douglas CW, Heath J, Rees C, Preston FE. Evidence for the involvement of complement proteins in platelet aggregation by Streptococcus sanguis NCTC 7863. Br J Haematol 1996;94(4):729–739
   PubMedGoogle Scholar
• Erickson PR, Herzberg MC. Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen from the surface of Streptococcus sanguis. J Biol Chem 1990;265(24):14080–14087
   PubMedGoogle Scholar
• Kerrigan SW, Douglas I, Wray A, Heath J, Byrne MF, Fitzgerald D, Cox D. A role for glycoprotein Ib in Streptococcus sanguis-induced platelet aggregation. Blood 2002;100(2):509–516
   PubMed Web of Science ®Google Scholar
• Douglas CW, Brown PR, Preston FE. Platelet aggregation by oral streptococci. FEMS Microbiol Lett 1990;60(1–2):63–67
   PubMedGoogle Scholar
• Ford I, Douglas CW, Preston FE, Lawless A, Hampton KK. Mechanisms of platelet aggregation by Streptococcus sanguis, a causative organism in infective endocarditis. Br J Haematol 1993;84(1):95–100
   PubMedGoogle Scholar
• Ford I, Douglas CW. The role of platelets in infective endocarditis. Platelets 1997;8(5):285–294
   PubMedGoogle Scholar
• Soberay AH, Herzberg MC, Rudney JD, Nieuwenhuis HK, Sixma JJ, Seligsohn U. Responses of platelets to strains of Streptococcus sanguis: Findings in healthy subjects, Bernard-Soulier, Glanzmann's, and collagen-unresponsive patients. Thromb Haemost 1987;57(2):222–225
   PubMedGoogle Scholar
• Kerrigan SW, Cox D. Platelet-bacterial interactions. Cell Mol Life Sci 2010;67(4):513–523
   PubMed Web of Science ®Google Scholar
• Erickson PR, Herzberg MC. The Streptococcus sanguis platelet aggregation-associated protein. Identification and characterization of the minimal platelet-interactive domain. J Biol Chem 1993;268(3):1646–1649
   PubMedGoogle Scholar
• Herzberg MC, Meyer MW. Effects of oral flora on platelets: Possible consequences in cardiovascular disease. J Periodontol 1996;67(10 Suppl):1138–1142
   Google Scholar
• Legrand YJ, Karniguian A, Le Francier P, Fauvel F, Caen JP. Evidence that a collagen-derived nonapeptide is a specific inhibitor of platelet-collagen interaction. Biochem Biophys Res Commun 1980;96(4):1579–1585
   PubMedGoogle Scholar
• Pintigny D, Legrand C, Karniguian A, Legrand YJ, Caen JP. Evidence that a collagen derived octapeptide inhibits fibrinogen binding to platelets stimulated by collagen and not by ADP. Biochem Biophys Res Commun 1985;128(2):547–553
   PubMedGoogle Scholar
• Herzberg MC, Nobbs A, Tao L, Kilic A, Beckman E, Khammanivong A, Zhang Y. Oral streptococci and cardiovascular disease: Searching for the platelet aggregation-associated protein gene and mechanisms of Streptococcus sanguis-induced thrombosis. J Periodontol 2005;76(11 Suppl):2101–2105
   Google Scholar
• Kerrigan SW, Cox D. The thrombotic potential of oral pathogens. J Oral Microbiol 2009;1:1–10
   Google Scholar
• McNicol A, Israels SJ. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharm 2010;88(5):510–524
   PubMedGoogle Scholar
• McNicol A, Zhu R, Pesun R, Pampolina C, Jackson EC, Bowden GH, Zelinski T. A role for immunoglobulin G in donor-specific Streptococcus sanguis-induced platelet aggregation. Thromb Haemost 2006;95(2):288–293
   PubMedGoogle Scholar
• Tilley DO, Arman M, Smolenski A, Cox D, O'Donnell JS, Douglas CW, Watson SP, Kerrigan SW. Glycoprotein Ibalpha and FcgammaRIIa play key roles in platelet activation by the colonizing bacterium, Streptococcus oralis. J Thromb Haemost 2013;11(5):941–950
   PubMedGoogle Scholar
• Ford I, Douglas CW, Cox D, Rees DG, Heath J, Preston FE. The role of immunoglobulin G and fibrinogen in platelet aggregation by Streptococcus sanguis. Br J Haematol 1997;97(4):737–746
   PubMedGoogle Scholar
• Sullam PM, Jarvis GA, Valone FH. Role of immunoglobulin G in platelet aggregation by viridans group streptococci. Infect Immun 1988;56(11):2907–2911
   PubMedGoogle Scholar
• Pampolina C, McNicol A. Streptococcus sanguis-induced platelet activation involves two waves of tyrosine phosphorylation mediated by FcgammaRIIA and alphaIIbbeta3. Thromb Haemost 2005;93(5):932–939
   PubMed Web of Science ®Google Scholar
• Stalker TJ, Newman DK, Ma P, Wannemacher KM, Brass LF. Platelet signaling. Handb Exp Pharmacol 2012;210:59–85
   Google Scholar
• Ragab A, Séverin S, Gratacap MP, Aguado E, Malissen M, Jandrot-Perrus M, Malissen B, Ragab-Thomas J, Payrastre B. Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: Insights into the mechanism of PLC gamma 2 activation. Blood 2007;110(7):2466–2474
   PubMedGoogle Scholar
• Moraes LA, Barrett NE, Jones CI, Holbrook LM, Spyridon M, Sage T, Newman DK, Gibbins JM. Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells. J Thromb Haemost 2010;8(11):2530–2541
   PubMedGoogle Scholar
• Abdulrehman AY, Jackson EC, McNicol A. Platelet activation by Streptococcus sanguinis is accompanied by MAP kinase phosphorylation. Platelets 2013;24(1):6–14
   PubMed Web of Science ®Google Scholar
• Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ. Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. Blood 2008;112(7):2780–2786
   PubMed Web of Science ®Google Scholar
• Zhi H, Rauova L, Hayes V, Gao C, Boylan B, Newman DK, McKenzie SE, Cooley BC, Poncz M, Newman PJ. Cooperative integrin/ITAM signaling in platelets enhances thrombus formation in vitro and in vivo. Blood 2013;121(10):1858–1867
   PubMed Web of Science ®Google Scholar
• Petersen HJ, Keane C, Jenkinson HF, Vickerman MM, Jesionowski A, Waterhouse JC, Cox D, Kerrigan SW. Human platelets recognize a novel surface protein, PadA, on Streptococcus gordonii through a unique interaction involving fibrinogen receptor GPIIbIIIa. Infect Immun 2010;78(1):413–422
   PubMed Web of Science ®Google Scholar
• Keane C, Petersen H, Reynolds K, Newman DK, Cox D, Jenkinson HF, Newman PJ, Kerrigan SW. Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. Arterioscler Thromb Vasc Biol 2010;30(12):2408–2415
   PubMed Web of Science ®Google Scholar
• McNicol A, Agpalza A, Jackson EC, Hamzeh-Cognasse H, Garraud O, Cognasse F. Streptococcus sanguinis-induced cytokine release from platelets. J Thromb Haemost, 2011;9(10):2038–2049
   PubMed Web of Science ®Google Scholar
• Kasper B, Petersen F. Molecular pathways of platelet factor 4/CXCL4 signaling. Eur J Cell Biol 2011;90(6–7):521–526
   PubMed Web of Science ®Google Scholar
• van Nispen tot Pannerden H, de Haas F, Geerts W, Posthuma G, van Dijk S, Heijnen HF. The platelet interior revisited: Electron tomography reveals tubular alpha-granule subtypes. Blood 2010;116(7):1147–1156
   PubMed Web of Science ®Google Scholar
• Italiano Jr JE, Battinelli EM. Selective sorting of alpha-granule proteins. J Thromb Haemost 2009;7(Suppl 1):173–176
   PubMed Web of Science ®Google Scholar
• Borsch-Haubold AG, Kramer RM, Watson SP. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Eur J Biochem 1997;245(3):751–759
   PubMedGoogle Scholar
• Plummer C, Wu H, Kerrigan SW, Meade G, Cox D, Ian Douglas CW. A serine-rich glycoprotein of Streptococcus sanguis mediates adhesion to platelets via GPIb. Br J Haematol 2005;129(1):101–109
   PubMed Web of Science ®Google Scholar
• McNicol A, Eyer E, Jackson EC, Israels SJ. A role for von Willebrand factor in Streptococcus sanguis-induced platelet activation. Thromb Haemost 2007;98(6):1382–1384
   PubMedGoogle Scholar
• Ozaki Y, Asazuma N, Suzuki-Inoue K, Berndt MC. Platelet GPIb-IX-V-dependent signaling. J Thromb Haemost 2005;3(8):1745–1751
   PubMedGoogle Scholar
• Takahashi Y, Yajima A, Cisar JO, Konishi K. Functional analysis of the Streptococcus gordonii DL1 sialic acid-binding adhesin and its essential role in bacterial binding to platelets. Infect Immun 2004;72(7):3876–3882
   PubMedGoogle Scholar
• Bensing BA, Lopez JA, Sullam PM. The Streptococcus gordonii surface proteins GspB and Hsa mediate binding to sialylated carbohydrate epitopes on the platelet membrane glycoprotein Ibalpha. Infect Immun 2004;72(11):6528–6537
   PubMed Web of Science ®Google Scholar
• Plummer C, Douglas CW. Relationship between the ability of oral streptococci to interact with platelet glycoprotein Ibalpha and with the salivary low-molecular-weight mucin, MG2. FEMS Immunol Med Microbiol 2006;48(3):390–399
   PubMedGoogle Scholar
• Peerschke EI, Murphy TK, Ghebrehiwet B. Activation-dependent surface expression of gC1qR/p33 on human blood platelets. Thromb Haemost 2003;89(2):331–339
   PubMedGoogle Scholar
• Herzberg MC, Brintzenhofe KL. ADP-like platelet aggregation activity generated by viridans streptococci incubated with exogenous ATP. Infect Immun 1983;40(1):120–125
   PubMedGoogle Scholar
• Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol 2002;3(9):639–650
   PubMed Web of Science ®Google Scholar
• Lova P, Paganini S, Sinigaglia F, Balduini C, Torti M. A Gi-dependent pathway is required for activation of the small GTPase Rap1B in human platelets. J Biol Chem 2002;277(14):12009–12015
   PubMed Web of Science ®Google Scholar
• Herzberg MC, Krishnan LK, MacFarlane GD. Involvement of alpha 2-adrenoreceptors and G proteins in the modulation of platelet secretion in response to Streptococcus sanguis. Crit Rev Oral Biol Med 1993;4(3–4):435–442
   PubMedGoogle Scholar
• Nash CA, Séverin S, Dawood BB, Makris M, Mumford A, Wilde J, Senis YA, Watson SP. Src family kinases are essential for primary aggregation by G(i)-coupled receptors. J Thromb Haemost 2010;8(10):2273–2282
   PubMed Web of Science ®Google Scholar
• Zimmerman TS, Spiegelberg HL. Pneumococcus-induced serotonin release from human platelets. Identification of the participating plasma/serum factor as immunoglobulin. J Clin Invest 1975;56(4):828–834
   PubMedGoogle Scholar
• Keane C, Tilley D, Cunningham A, Smolenski A, Kadioglu A, Cox D, Jenkinson HF, Kerrigan SW. Invasive Streptococcus pneumoniae trigger platelet activation via Toll-like receptor 2. J Thromb Haemost 2010;8(12):2757–2765
   PubMedGoogle Scholar
• Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol 2005;83(2):196–198
   PubMed Web of Science ®Google Scholar
• Sullam PM, Bayer AS, Foss WM, Cheung AL. Diminished platelet binding in vitro by Staphylococcus aureus is associated with reduced virulence in a rabbit model of infective endocarditis. Infect Immun 1996;64(12):4915–4921
   PubMedGoogle Scholar
• O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, Fitzgerald DJ, Foster TJ, Cox D. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: Roles for the clumping factors ClfA and ClfB, the serine-aspartate repeat protein SdrE and protein A. Mol Microbiol 2002;44(4):1033–1044
   PubMed Web of Science ®Google Scholar
• de Haas CJ, Weeterings C, Vughs MM, de Groot PG, Van Strijp JA, Lisman T. Staphylococcal superantigen-like 5 activates platelets and supports platelet adhesion under flow conditions, which involves glycoprotein Ibalpha and alpha IIb beta 3. J Thromb Haemost 2009;7(11):1867–1874
   PubMedGoogle Scholar
• Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D, Foster TJ. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol 2005;57(3):804–818
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhao L, Liu J, Du J, Yan R, Dai K. Role of 14-3-3ζ in Platelet Glycoprotein Ibα-von Willebrand Factor Interaction-Induced Signaling. Int J Mol Sci. 2012;13(5):5364–5374
   Google Scholar
• Andrews RK, Du X, Berndt MC. The 14–3-3zeta-GPIb-IX-V complex as an antiplatelet target. Drug News Perspect 2007;20(5):285–292
   PubMedGoogle Scholar
• Whitaker EJ, Thomas IS, Falk JA, Obebe A, Hammond BF. Effect of acetylsalicylic acid on aggregation of human platelets by Porphyromonas gingivalis. Gen Dent 2007;55(1):64–69; quiz 70, 79–80
   PubMedGoogle Scholar
• McNicol A, Israels SJ. Mechanisms of oral bacteria-induced platelet activation. Can J Physiol Pharmacol 2010;88(5):510–524
   PubMedGoogle Scholar
• Potempa J, Sroka A, Imamura T, Travis J. Gingipains, the major cysteine proteinases and virulence factors of Porphyromonas gingivalis: structure, function and assembly of multidomain protein complexes. Curr Protein Pept Sci 2003;4(6):397–407
   PubMed Web of Science ®Google Scholar
• Lourbakos A, Yuan YP, Jenkins AL, Travis J, Andrade-Gordon P, Santulli R, Potempa J, Pike RN. Activation of protease-activated receptors by gingipains from Porphyromonas gingivalis leads to platelet aggregation: A new trait in microbial pathogenicity. Blood 2001;97(12):3790–3797
   PubMed Web of Science ®Google Scholar
• Naito M, Sakai E, Shi Y, Ideguchi H, Shoji M, Ohara N, Yamamoto K, Nakayama K. Porphyromonas gingivalis-induced platelet aggregation in plasma depends on Hgp44 adhesin but not Rgp proteinase. Mol Microbiol 2006;59(1):152–167
   PubMed Web of Science ®Google Scholar
• Gibson FC III, Ukai T, Genco CA. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front Biosci 2008;13:2041–2059
   PubMed Web of Science ®Google Scholar
• Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y, Ejiri J, Kobayashi S, Hirata K, Kawashima S, Yokoyama M. Expression of Toll-like receptors on human platelets. Thromb Res 2004;113(6):379–385
   PubMedGoogle Scholar
• Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, Dower SK, Buttle DJ, Sabroe I. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost 2005;94(4):831–838
   PubMed Web of Science ®Google Scholar
• Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Pozzetto B, McNicol A, Garraud O. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol 2008;141(1):84–91
   PubMed Web of Science ®Google Scholar
• Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, Ni H, Lazarus AH, Freedman J, Semple JW. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 2006;107(2):637–641
   PubMed Web of Science ®Google Scholar
• Shashkin PN, Brown GT, Ghosh A, Marathe GK, McIntyre TM. Lipopolysaccharide is a direct agonist for platelet RNA splicing. J Immunol 2008;81(5):3495–3502
   Google Scholar
• Assinger A, Laky M, Badrnya S, Esfandeyari A, Volf I. Periodontopathogens induce expression of CD40L on human platelets via TLR2 and TLR4. Thromb Res 2012;130(3):e73–e78
   PubMedGoogle Scholar
• Troutman TD, Bazan JF, Pasare C. Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K. Cell Cycle 2012;11(19):3559–3567
   PubMed Web of Science ®Google Scholar
• Clark K. Protein kinase networks that limit TLR signalling. Biochem Soc Trans 2014;42(1):11–24
   PubMedGoogle Scholar
• Sun D, Popescu NI, Raisley B, Keshari RS, Dale GL, Lupu F, Coggeshall KM. Bacillus anthracis peptidoglycan activates human platelets through FcgammaRII and complement. Blood 2013;122(4):571–579
   PubMedGoogle Scholar
• Lhermusier T, Chap H, Payrastre B. Platelet membrane phospholipid asymmetry: From the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost 2011;9(10):1883–1891
   PubMed Web of Science ®Google Scholar
• Bergmeier W, Oh-Hora M, McCarl CA, Roden RC, Bray PF, Feske S. R93W mutation in Orai1 causes impaired calcium influx in platelets. Blood 2009;113(3):675–678
   PubMed Web of Science ®Google Scholar
• Gilio K, van Kruchten R, Braun A, Berna-Erro A, Feijge MA, Stegner D, van der Meijden PE, Kuijpers MJ, Varga-Szabo D, Heemskerk JW, et al. Roles of platelet STIM1 and Orai1 in glycoprotein VI- and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem 2010;285(31):23629–23638
   PubMed Web of Science ®Google Scholar
• Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med 2002;30(5 Suppl):S313–S317
   PubMed Web of Science ®Google Scholar